openPR Logo
Press release

US Pharmaceutical Contract Manufacturing Market Research and Forecast 2018-2023

01-08-2020 09:34 AM CET | Science & Education

Press release from: Orion Market Research Pvt. Ltd.

US Pharmaceutical Contract Manufacturing Market Research

The US pharmaceutical contract manufacturing market is growing at a significant rate of 6.8% during the forecast period (2019-2025). The US pharmaceutical contract manufacturing market is highly fragmented in nature. There are several small to medium companies that are providing pharmaceutical services on a contract basis to other firms. In recent years, the volume of generic drug sales has increased rapidly in the US, whereas, the outsourcing of branded pharmaceuticals in the US has been growing at a significant rate due to the lack of any production capacity constraint with pharmaceutical companies.

A full report description of US Pharmaceutical Contract Manufacturing Market Research and Forecast 2018-2023 at https://www.omrglobal.com/industry-reports/us-pharmaceutical-contract-manufacturing-market

A large number of branded pharmaceuticals have moved towards maturity and late growth stages in the product life cycle. Hence, utilization levels of these plants are likely to grow to unsustainable levels. This makes outsourcing a viable option for many pharmaceutical companies operating in the region. There are several major players in the market, which include Thermo Fisher Scientific, Inc., Catalent, Inc., Pfizer CenterOne, Baxter International, Inc., and AbbVie, Inc. Apart from these, various small players are operating in the market that are offering API, drug formulation, and other drug development and manufacturing services to pharmaceutical companies.

To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/us-pharmaceutical-contract-manufacturing-market

For instance, Lief Organics and Paragon Laboratories are working as a contract manufacturer in finished dosage formulation. In addition, AbbVie, Inc. and Cambrex Corp. are offering contract manufacturing service for API. Therefore, the US pharmaceutical contract manufacturing market is highly diversified due to the presence of several small and large players that are offering different kinds of pharmaceutical manufacturing services.

Mergers and acquisitions are key strategies adopted by market players operating in the US pharmaceutical contract manufacturing industry

The companies providing pharmaceutical products and services in the US are actively seeking mergers and acquisitions as a key strategy over the last decades. Through mergers and acquisitions, a company can reduce the impact of a particular industry’s performance on its profitability. The companies seeking mergers and acquisitions often merge with companies that have deeper market penetration and expertise in a particular area of operation. This enables the company to have a strong foothold in that particular area and to strengthen its revenue stream.

Significant mergers and acquisitions have been observed in the US pharmaceutical contract manufacturing market over the decades. For instance, in August 2017, Thermo Fisher Scientific Inc. acquired Patheon N.V., a CDMO for nearly $7.2 billion that serves the biotechnology and pharmaceutical sectors. This acquisition would enable the company to expand its contract manufacturing service for biotech and pharmaceutical firms. Moreover, in April 2019, Catalent, Inc. acquired Paragon Bioservices, Inc. for $1.2 billion. Paragon is a CDMO engaged in the development and production of biopharmaceuticals. This acquisition will enable to fundamentally increase the biologics business of Catalent and its end-to-end integrated biopharmaceutical solutions for customers.

Current Market Trends Covered in the US Pharmaceutical Contract Manufacturing Market Report

• Based on the category, the human-based drugs segment is estimated to hold a dominating market share during the forecast period.
• Based on the product, API held the largest market share in the US pharmaceutical contract manufacturing market in 2018.
• Based on the services, manufacturing services held the largest market share in the US pharmaceutical contract manufacturing market in 2018.

US Pharmaceutical Contract Manufacturing Market Segmentation

By Category

• Animal-based Drugs
• Human-based Drugs

By Product

• Active Pharmaceutical Ingredient
• OTC Drugs
• FDF
• Others

By Services

• R&D
• Manufacturing Services
• Non-Clinical Services

Key Players of Pharmaceutical Contract Manufacturing Market Report are:

• Teva Pharmaceuticals
• Piramal Pharma Solutions
• Reddy’s Laboratories
• Abbott Laboratories
• Sun Pharmaceutical
• Cobra Biologics
• Ranbaxy Laboratories
• MabPlex
• Wockhardt
• Cytovance Biologics

Media Contact:

Company Name: Orion Market Research
Contact Person: Mr. AnuragTiwari
Email: info@omrglobal.com
Contact no: +1 646-755-7667, +91 780-304-0404
Source: US Pharmaceutical Contract Manufacturing Market

About Orion Market Research

Orion Market Research (OMR) is an Indian market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release US Pharmaceutical Contract Manufacturing Market Research and Forecast 2018-2023 here

News-ID: 1891578 • Views:

More Releases from Orion Market Research Pvt. Ltd.

Insurance CRM Software Market Trends, Business Overview, Industry Growth and Forecast to 2031
Insurance CRM Software Market Trends, Business Overview, Industry Growth and For …
The global insurance CRM software market is anticipated to grow at a significant CAGR during the forecast period. The major factor for the growth of the global insurance CRM software market during the forecast period is demand for the smart and automated technologies by the insurance companies. Get Free Sample link @ https://www.omrglobal.com/request-sample/insurance-crm-software-market-share The insurance CRM software will help the insurance companies with policy tracking, agent management, activity tracking, and many
Smart Meters Market 2022 Driving Factors Forecast Research 2028
Smart Meters Market 2022 Driving Factors Forecast Research 2028
The global market for smart meters is projected to have considerable CAGR of around 7.5% during the forecast period. The market growth mainly backed by the increasing inclination towards smart meters in place of conventional meters due to various advantages, such as theft detection and leakage management further raises the demand for smart meters across the globe. The smart meters provides theft and accurate billing and enhanced customer services by
Prostate Stents Market Current Status, In-depth Analysis and Forecast Outlook 20 …
A prostate stent is a medical device used to open the space surrounding the prostate urethra and bladder neck for smooth urine flow during urinary incontinence. These stents are effective in relieving bladder outlet obstruction caused by benign prostatic hyperplasia (common in men over 70). (Get 15% Discount on Buying this Report) Get Sample at: https://www.orionmarketreports.com/request-sample/?id=50469 Market Segments The global prostate stents market can be bifurcated into permanent and temporary. Several studies have
Rapid Pregnancy Tests Market Current Status, In-depth Analysis and Forecast Outl …
The pregnancy test kit confirms pregnancy by detecting the level of human chorionic gonadotropin (HCG) in the urine. The growing demand for an easy and convenient way to get faster results, and the easy availability of pregnancy kits through various distribution channels, including pharmacies/pharmacies, online stores, etc., is increasing the demand for pregnancy test kits. (Get 15% Discount on Buying this Report) Get Sample at: https://www.orionmarketreports.com/request-sample/?id=50471 Market Segments Based on product type The global

All 5 Releases


More Releases for Pharma

Miglitol Market Size, Share and Forecast By Key Players-Weiao Pharma, Zhejiang M …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Miglitol market is anticipated to grow at a compound annual growth rate (CAGR) of 11.49% between 2024 and 2031. The market is expected to grow to USD 22.32 Billion by 2024. The valuation is expected to reach USD 47.79 Billion by 2031. The Miglitol market is experiencing significant growth due to the rising prevalence of diabetes and the increasing awareness of the
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis. Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382 The Indomethacin Global Market Research Report provides close monitoring
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024. Global Roxatidine Market overview: Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the